SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000909661-99-000028
Filing Date
1999-12-09
Accepted
1999-12-09 00:00:00
Documents
1
Group Members
ANDREW B. FREMDERDAVID I. COHENENRIQUE BOILINIFARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.FARALLON CAPITAL MANAGEMENT LLCFARALLON CAPITAL PARTNERS, L.P.FARAL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 16 SC 13D/A 83629
  Complete submission text file 0000909661-99-000028.txt   86279
Mailing Address ONE MARITIME PLAZA SAN FRANCISCO CA 94111
Business Address ONE MARITIME PLAZA STE 11325 SAN FRANCISCO CA 94111 4154212132
FARALLON CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000909661 (see all company filings)

IRS No.: 943240279

Mailing Address 2525 DUPONT DRIVE IRVINE CA 92612
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142466912
ALLERGAN SPECIALTY THERAPEUTICS INC (Subject) CIK: 0001049711 (see all company filings)

IRS No.: 330779207 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-53925 | Film No.: 99771643
SIC: 2834 Pharmaceutical Preparations